Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan W Partin

Showing results (41-50 of 349) with videos related to

Pageof 35
Sort By:
Reviews in Urology|September 21, 2006
Expectant management of prostate cancerMasood A Khan, Alan W Partin
Reviews in Urology|May 13, 2008
Focal therapy for prostate cancerDanil V Makarov, Alan W Partin
Reviews in Urology|March 31, 2007
Postprostatectomy risk stratification based on detection of occult lymph node metastasisDanil V Makarov, Alan W Partin
Reviews in Urology|June 27, 2007
The impact of definitions of failure on the interpretation of biochemical recurrence following treatment of clinically localized prostate cancerMatthew E Nielsen, Alan W Partin
Reviews in Urology|October 6, 2018
Best of the 2018 AUA Annual MeetingZeyad R Schwen, Alan W Partin,
JAMA Surgery|July 4, 2014
Robotic prostatectomy diffusion safety concerns: reality or just illusion?Mohamad E Allaf, Alan W Partin
Reviews in Urology|September 21, 2006
Tissue microarrays in prostate cancer researchMasood A Khan, Alan W Partin
Reviews in Urology|September 21, 2006
54-year-old male with high-grade prostatic intraepithelial neoplasia on prostate biopsyMatthew B Gretzer, Alan W Partin
Reviews in Urology|September 21, 2006
Chemoprevention and prostate cancerMasood A Khan, Alan W Partin
Reviews in Urology|September 21, 2006
Evolving Role of Pro-PSA as a New Serum Marker for the Early Detection of Prostate CancerMasood A Khan, Alan W Partin
Pageof 35

Showing results (41-50 of 349) with videos related to

Sort By:
Pageof 35
Reviews in Urology|September 21, 2006
Expectant management of prostate cancerMasood A Khan, Alan W Partin
Reviews in Urology|May 13, 2008
Focal therapy for prostate cancerDanil V Makarov, Alan W Partin
Reviews in Urology|March 31, 2007
Postprostatectomy risk stratification based on detection of occult lymph node metastasisDanil V Makarov, Alan W Partin
Reviews in Urology|June 27, 2007
The impact of definitions of failure on the interpretation of biochemical recurrence following treatment of clinically localized prostate cancerMatthew E Nielsen, Alan W Partin
Reviews in Urology|October 6, 2018
Best of the 2018 AUA Annual MeetingZeyad R Schwen, Alan W Partin,
JAMA Surgery|July 4, 2014
Robotic prostatectomy diffusion safety concerns: reality or just illusion?Mohamad E Allaf, Alan W Partin
Reviews in Urology|September 21, 2006
Tissue microarrays in prostate cancer researchMasood A Khan, Alan W Partin
Reviews in Urology|September 21, 2006
54-year-old male with high-grade prostatic intraepithelial neoplasia on prostate biopsyMatthew B Gretzer, Alan W Partin
Reviews in Urology|September 21, 2006
Chemoprevention and prostate cancerMasood A Khan, Alan W Partin
Reviews in Urology|September 21, 2006
Evolving Role of Pro-PSA as a New Serum Marker for the Early Detection of Prostate CancerMasood A Khan, Alan W Partin
Pageof 35